New Low-cost Device Rapidly, Accurately Detects Hepatitis C Infection

The entire virus detection process is executed inside a uniquely designed, portable, inexpensive, disposable, and self-driven microfluidic chip. The fully automated sample-in–answer-out molecular diagnostic set-up rapidly detects Hepatitis C virus in about 45 minutes and uses relatively inexpensive and reusable equipment costing about $50 for sample processing and disease detection. The disposable microfluidic chip also offers shorter times for a reliable diagnosis and costs about $2.

Open Lab Solutions Announces New Manufacturing Division to Initially focus on Medical Plastics

CHICAGO, July 26, 2022 /PRNewswire/ — AACC 2022 Open Lab Solutions, Inc., is announcing the formation of a new division, AMCAR Scientific, that will focus on an expanding product line of plastic consumables used in the medical industry. OLS is exhibiting within booth #3257 at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2022) at the McCormick Place Convention Center in Chicago, July 24 – 28th.

Association for Molecular Pathology Reinforces Continued Commitment to Improving National Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization’s continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting

Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the launch of its respiratory syncytial virus test (RSV). Mesa will demonstrate its expanded, novel Accula™ Test System at the 71st American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo. The Accula System’s RSV and Flu A/Flu B molecular tests will be on exhibit in Booth 3902. Sekisui Diagnostics distributes both products in the US under the Silaris™ brand.